Summary of Concerns at Spectral Medical inc. Spectral Medical Inc.
Notice to ALL Shareholders
Annual General & Special Meeting of The Shareholders of
Spectral Medical Inc. to be held:
June 7, 2023, at 4 pm Toronto time.
Your Online Vote Must be in by June 4, 2023, 11:59 pm EDT
If You Have Voted Online and You Want to CHANGE Your Vote, You Are Able to Change your Vote Online,
IT MUST BE Changed
BEFORE June 4, 2023, 11.59 pm EDT
Summary of Critical Concerns at Spectral Medical Inc.
This is a brief summary of my previous deep dive post, I addressed critical concerns at Spectral Medical Inc. Shareholders must act swiftly to address the alarming decline in market capitalization, falling share prices, and questionable compensation practices.
1.
Alarming Market Decline: Under CEO Chris Seto, Spectral Medical Inc. has experienced a significant drop in market capitalization and share prices, raising doubts about effective leadership.
2.
Questionable Compensation: Despite the company's value plunging, CEO Chris Seto received substantial compensation, while additional stock incentives were granted to the board and executives, suggesting a misalignment with shareholder interests.
3.
Neglected Shareholder Concerns: Limited accessibility for American investors and a lack of shareholder dialogue further contribute to concerns surrounding Spectral Medical Inc.
4.
The disparity in Returns: Shareholders have not seen returns on their investments, while the board and management continue to receive substantial compensation and stock incentives.
5.
Failing Duty to Shareholders: The board of directors has failed to effectively represent shareholder interests, warranting a vote to
WITHHOLD support for each director.
Conclusion: Immediate action is essential to address critical issues at Spectral Medical Inc. Shareholders must exercise their voting rights to remove current directors and demand leadership that prioritizes shareholder value. Time is of the essence to protect the intrinsic value of shareholders' investments. I will WITHHOLD my vote for the re-election of ALL Directors Key Takeaway’s 1. Spectral Medical Inc.'s
value has plummeted by over 58% under CEO Chris Seto's leadership.
2. The Board and Management prioritize their own compensation over the interests of shareholders.
3. Shareholders have been neglected by the current leadership at Spectral Medical Inc.
4. Despite the potential impact of the company's technology on global sepsis cases, the story remains untold, and U.S. investors face difficulties in participating due to the lack of a U.S. listing.
5. It is crucial to vote to
WITHHOLD the re-election of the directors if you are dissatisfied with the current leadership.
6. Share this information with fellow shareholders to raise awareness.
Always invest only that which you can afford to lose. Always seek professional investment advice when making decisions about your investments. At ALL times Do Your Own Research on your investments.